Evidence map›Paper›PMID 33411788›Full record

ArticlePLoS genetics2021

Aberrant regulation of a poison exon caused by a non-coding variant in a mouse model of Scn1a-associated epileptic encephalopathy.

Yuliya Voskobiynyk, Gopal Battu, Stephanie A Felker, J Nicholas Cochran, Megan P Newton, Laura J Lambert, Robert A Kesterson, Richard M Myers, Gregory M Cooper, Erik D Roberson and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. TDP-43: [GU]-ardian of the transcriptome.Molecular neurodegeneration · 2026
    Review
  6. CharacterizingmedRxiv : the preprint server for health sciences · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Dravet syndrome: novel insights intoFrontiers in neuroscience · 2025
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Brain expression profiles of twoTranslational neuroscience · 2024
    Article
  20. Targeted Molecular Strategies for Genetic Neurodevelopmental Disorders: Emerging Lessons from Dravet Syndrome.The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry · 2023
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Yuliya VoskobiynykCenter for Neurodegeneration and Experimental Therapeutics, Alzheimer's Disease Center, and Evelyn F. McKnight Brain Institute, Departments, of Neurology and Neurobiology, University of Alabama at Birmingham, Birmingham, AL, United States of America.ORCID 0000-0003-4169-3002
Gopal BattuHudsonAlpha Institute for Biotechnology, Huntsville, AL, United States of America.ORCID 0000-0002-3042-6518
Stephanie A FelkerHudsonAlpha Institute for Biotechnology, Huntsville, AL, United States of America.ORCID 0000-0002-1809-1524
J Nicholas CochranHudsonAlpha Institute for Biotechnology, Huntsville, AL, United States of America.ORCID 0000-0002-9852-5504
Megan P NewtonDepartment of Genetics, University of Alabama at Birmingham, Birmingham, AL, United States of America.ORCID 0000-0002-4879-2807
Laura J LambertDepartment of Genetics, University of Alabama at Birmingham, Birmingham, AL, United States of America.ORCID 0000-0001-6227-1445
Robert A KestersonDepartment of Genetics, University of Alabama at Birmingham, Birmingham, AL, United States of America.ORCID 0000-0003-1331-0780
Richard M MyersHudsonAlpha Institute for Biotechnology, Huntsville, AL, United States of America.ORCID 0000-0001-9701-676X
Gregory M CooperHudsonAlpha Institute for Biotechnology, Huntsville, AL, United States of America.ORCID 0000-0001-5509-9923
Erik D RobersonCenter for Neurodegeneration and Experimental Therapeutics, Alzheimer's Disease Center, and Evelyn F. McKnight Brain Institute, Departments, of Neurology and Neurobiology, University of Alabama at Birmingham, Birmingham, AL, United States of America.ORCID 0000-0002-1810-9763
Gregory S BarshHudsonAlpha Institute for Biotechnology, Huntsville, AL, United States of America.ORCID 0000-0002-0838-1042
HudsonAlpha Institute for Biotechnology · USUniversity of Alabama at Birmingham · US

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Robert S Welner · 1985 to 2026
$165.9M
UAB Recessive PKD Research and Translational Core CenterP30DK074038 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI YODER, BRADLEY K. · 2005 to 2019
$16.6M
UAB Pilot Center for Precision Animal Modeling (C-PAM) - Resource and Service SectionU54OD030167 · OD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Deeann Wallis-Schultz · 2020 to 2026
$15.3M
South-seq: DNA sequencing for newborn nurseries in the SouthU01HG007301 · NHGRI · HUDSON-ALPHA INSTITUTE FOR BIOTECHNOLOGY · PI BARSH, GREGORY STEFAN, COOPER, GREGORY MICHAEL · 2017 to 2021
$11.9M
ROS Modulation of Innate and Adaptive Immunity in RAP30AR048311 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MOUNTZ, JOHN D · 2001 to 2017
$9.5M
UAB Diabetes Research and Training CenterP60DK079626 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GARVEY, W TIMOTHY · 2008 to 2012
$8.4M
Transcription factor function in healthy and psychiatric disorder-affected brainsR01MH110472 · NIMH · HUDSON-ALPHA INSTITUTE FOR BIOTECHNOLOGY · PI COOPER, GREGORY MICHAEL, MYERS, RICHARD M · 2017 to 2021
$6.0M
NCI NIH HHS P30 CA013148NHGRI NIH HHS U01 HG007301NIAMS NIH HHS P30 AR048311NIDDK NIH HHS P30 DK074038NIDDK NIH HHS P60 DK079626NIH HHS U54 OD030167NIMH NIH HHS R01 MH110472
6 · The paper itself

Abstract

Dravet syndrome (DS) is a developmental and epileptic encephalopathy that results from mutations in the Nav1.1 sodium channel encoded by SCN1A. Most known DS-causing mutations are in coding regions of SCN1A, but we recently identified several disease-associated SCN1A mutations in intron 20 that are within or near to a cryptic and evolutionarily conserved "poison" exon, 20N, whose inclusion is predicted to lead to transcript degradation. However, it is not clear how these intron 20 variants alter SCN1A expression or DS pathophysiology in an organismal context, nor is it clear how exon 20N is regulated in a tissue-specific and developmental context. We address those questions here by generating an animal model of our index case, NM_006920.4(SCN1A):c.3969+2451G>C, using gene editing to create the orthologous mutation in laboratory mice. Scn1a heterozygous knock-in (+/KI) mice exhibited an ~50% reduction in brain Scn1a mRNA and Nav1.1 protein levels, together with characteristics observed in other DS mouse models, including premature mortality, seizures, and hyperactivity. In brain tissue from adult Scn1a +/+ animals, quantitative RT-PCR assays indicated that ~1% of Scn1a mRNA included exon 20N, while brain tissue from Scn1a +/KI mice exhibited an ~5-fold increase in the extent of exon 20N inclusion. We investigated the extent of exon 20N inclusion in brain during normal fetal development in RNA-seq data and discovered that levels of inclusion were ~70% at E14.5, declining progressively to ~10% postnatally. A similar pattern exists for the homologous sodium channel Nav1.6, encoded by Scn8a. For both genes, there is an inverse relationship between the level of functional transcript and the extent of poison exon inclusion. Taken together, our findings suggest that poison exon usage by Scn1a and Scn8a is a strategy to regulate channel expression during normal brain development, and that mutations recapitulating a fetal-like pattern of splicing cause reduced channel expression and epileptic encephalopathy.

Indexed as

AnimalsBrainDisease Models, AnimalEpilepsies, MyoclonicExonsGene Expression RegulationGene Knock-In TechniquesHumansIntronsMiceMutationNAV1.1 Voltage-Gated Sodium ChannelNAV1.6 Voltage-Gated Sodium ChannelOrgan SpecificityRNA-SeqNAV1.1 Voltage-Gated Sodium ChannelNAV1.6 Voltage-Gated Sodium ChannelSCN1A protein, humanScn1a protein, mouseScn8a protein, mouse

Identifiers

PMID33411788
PMCPMC7790302
OpenAlexW3119453872

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.